Coveted MR prize awarded to Cain
Before joining Schering-Plough, Cain, who is also PMRG outgoing president, led marketing research teams at Pharmacia and at Bristol-Myers Squibb.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.
Click the link below to access the Digital Edition of the June 2015 issue of MM&M, with all text, charts and pictures.
Perhaps the best testament to Commissioner Hamburg's tenure is that crises were uniformly handled responsibly
In Jack Welch's view, one of the worst mistakes a manager can make is . . .